FibroGen Inc (FGEN) — Working Capital to Net Assets Ratio
FibroGen Inc (FGEN) has a Working Capital to Net Assets ratio of 557.3% as of September 2025. Working capital of $97.45 Million (current assets of $133.42 Million minus current liabilities of $35.97 Million) is measured against net assets of $17.48 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See FGEN FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
FibroGen Inc Working Capital to Net Assets (2012–2024)
This chart shows how FibroGen Inc's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 557.3%, reflecting working capital of $97.45 Million against net assets of $17.48 Million USD. See operational self-sufficiency of FibroGen Inc to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for FibroGen Inc (2012–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for FibroGen Inc from 2012 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see FGEN company net worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -34.4% | $63.20 Million | $-183.63 Million | $196.51 Million | $133.31 Million | ▲ +35.8 pp |
| 2023 | -70.2% | $113.89 Million | $-162.20 Million | $331.56 Million | $217.67 Million | ▲ +14744.9 pp |
| 2022 | -14815.1% | $219.26 Million | $-1.48 Million | $492.83 Million | $273.56 Million | ▼ -14923.6 pp |
| 2021 | 108.5% | $248.56 Million | $229.11 Million | $474.06 Million | $225.50 Million | ▼ -25.6 pp |
| 2020 | 134.1% | $591.92 Million | $441.45 Million | $755.11 Million | $163.19 Million | ▲ +22.1 pp |
| 2019 | 112.0% | $599.75 Million | $535.41 Million | $702.49 Million | $102.75 Million | ▼ -1.7 pp |
| 2018 | 113.7% | $600.98 Million | $528.47 Million | $690.01 Million | $89.03 Million | ▼ -1.6 pp |
| 2017 | 115.3% | $671.71 Million | $582.45 Million | $748.97 Million | $77.26 Million | ▲ +0.3 pp |
| 2016 | 115.0% | $201.39 Million | $175.11 Million | $266.52 Million | $65.12 Million | ▲ +47.2 pp |
| 2015 | 67.8% | $133.38 Million | $196.82 Million | $200.56 Million | $67.18 Million | ▲ +11.5 pp |
| 2014 | 56.3% | $135.48 Million | $240.68 Million | $198.24 Million | $62.75 Million | ▼ -42.4 pp |
| 2013 | 98.7% | $106.16 Million | $107.60 Million | $143.64 Million | $37.48 Million | ▲ +74.8 pp |
| 2012 | 23.8% | $29.12 Million | $122.18 Million | $52.80 Million | $23.68 Million | — |